PSTakeCare’s solution is available to patients in a few areas in Mumbai and will be launched in other metros during the course of this year
Portea Medical, home healthcare provider, has picked up majority stake in health-tech startup, PSTakeCare, whose platform connects key stakeholders in the healthcare delivery ecosystem. Further details on the investment were not disclosed.
PSTakeCare was formed in March 2015 by Pratik Chinchole, Rahil Momin, Anup Raaj, graduates of IIT Bombay, and Shirin Shinde, who studied at the Institute of Chemical Technology, Mumbai.
“Portea is very pleased to underline our commitment to enhancing healthcare in India via this investment in PSTakeCare. Consumers globally are accelerating adoption of technology that underpins the most impactful healthcare solutions. The tech platform that PSTakeCare has built places the patient at the centre of the healthcare universe and this focus on the Patient is a shared goal for both companies,” said Meena Ganesh, MD & CEO, Portea Medical.
“Better informed patients and enhanced transparency among healthcare service providers will remove ambiguity and opaqueness, and ultimately benefit the healthcare system across the board. We look forward to further empowering healthcare consumers in India,” she added.
Reportedly, PSTakeCare’s technology equips healthcare consumers with relevant knowledge on doctors, hospitals and other healthcare service providers enabling consumers to take healthcare decisions based on factors such as insurance coverage provided, procedure-specific feedback and room-wise costs. In addition, the platform also presents actual photographs of medical facilities and uses advanced analytics and consumer feedback to provide comprehensive information to patients.
Pratik Chinchole, Co-Founder & CEO of PSTakeCare, said, “There is an urgent need for greater transparency in India’s healthcare system. We would like to become the first port-of-call for patients seeking information on doctors, hospitals and labs for any medical procedure. Going forward we will continue to focus on building disruptive products in healthcare solving key patient needs through innovation. With Portea, we have the right platform to rapidly scale the business.”
Elaborating PSTakeCare’s plans, he added that the solution was available to patients in a few areas in Mumbai and will launch in other metros during the course of this year.
Portea is also exploring other investments as the company expands its offerings to tackle the massive challenges brought on by India’s ageing population, the rising burden of NCDs (non-communicable diseases) and the huge gaps in healthcare infrastructure.
In September 2015, Portea received Series B funding of $37.5 million from Accel, IFC, Qualcomm Ventures and Ventureast. The investment in PSTakeCare follows Portea’s acquisition of speciality pharma distributor, MedybizPharma in November 2015.